Please use this identifier to cite or link to this item:
http://nopr.niscair.res.in/handle/123456789/12244| Title: | Therapeutics |
| Issue Date: | Feb-2003 |
| Publisher: | NISCAIR-CSIR, India |
| Abstract: | Hepatitis B Virus (HBV) is a causative agent of the most frequent viral infections of man. Since the non-humanhost range of HBV is restricted to a few animals, such as, chimpanzee, the development of new therapeutics for HBV has been hampered. Several cell lines were developed to identify potential therapeutics against HBV infection. |
| Page(s): | 30-37 |
| URI: | http://hdl.handle.net/123456789/12244 |
| Appears in Collections: | NPR Vol.2(1) [January-February 2003] |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| NPR 2(1) 30-37.pdf | 2.15 MB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.